Alnylam Pharmaceuticals
ALNY
#601
Rank
HK$252.14 B
Marketcap
HK$1,955
Share price
4.37%
Change (1 day)
33.29%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: HK$252.14 Billion

As of January 2025 Alnylam Pharmaceuticals has a market cap of HK$252.14 Billion. This makes Alnylam Pharmaceuticals the world's 601th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$252.14 B5.82%
2024HK$238.28 B27.02%
2023HK$187.60 B-17.88%
2022HK$228.44 B44.45%
2021HK$158.14 B35.1%
2020HK$117.05 B16.33%
2019HK$100.62 B74.2%
2018HK$57.76 B-41.32%
2017HK$98.44 B295.12%
2016HK$24.91 B-59.87%
2015HK$62.08 B6.89%
2014HK$58.08 B82.76%
2013HK$31.78 B328.03%
2012HK$7.42 B174.54%
2011HK$2.70 B-16.76%
2010HK$3.24 B-43.16%
2009HK$5.71 B-27.78%
2008HK$7.91 B-14.39%
2007HK$9.24 B49.91%
2006HK$6.16 B208.73%
2005HK$1.99 B78.44%
2004HK$1.11 B

End of Day market cap according to different sources

On Jan 15th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

HK$252.14 Billion
by Yahoo Finance info icon info icon
HK$252.14 Billion
by CompaniesMarketCap info icon info icon
HK$252.14 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$18.34 B-92.72%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$602.02 B 138.76%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$88.77 B-64.79%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$7.70 B-96.95%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.64 B-99.74%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.545 T 512.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$964.01 B 282.32%๐Ÿ‡ซ๐Ÿ‡ท France
HK$193.60 B-23.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel